This Month
Bain Capital seals Virgin’s ASX relisting as fundies commit to IPO
Brokers working on the transaction closed their books hours before expected amid a rush of demand for shares, which are expected to start trading this month.
Citi names new head of equity capital markets as Jahrling exits
Rob Jahrling’s departure comes after a tough period for the small but important profit centre for the Wall Street bank.
Melbourne Airport shops junior debt to fund capex
The notes are structured with a 30-year maturity, with a call date between five and seven years to induce the credit ratings agencies to assign equity credit.
Chemist Warehouse brigade sells another $200m of Sigma; eyes on insiders
It adds to the roughly $13.8 billion worth of Sigma Healthcare shares that have changes hands since Chemist Warehouse reverse-listed earlier this year.
Ex-Macquarie equities boss seeks $100m for investment firm
Factory Capital has pressed play on an equity raising as it seeks to stock up its balance sheet through family offices and high-net-worth investors.
Inside Bain’s Virgin pitch, and the one number investors will fear
A tightly held pathfinder prospectus reveals all the key financial metrics that the airline’s potential new shareholders can look forward to.
Fix the shrinking ASX before private markets, brokers urge ASIC
The corporate regulator is mulling feedback from almost 90 submissions on its review into Australia’s capital exchange.
BetMakers launches capital raise to fund Nevada acquisition
The wagering technology group will seek to raise the funds at a 10¢ fixed price – a tight 4.8 per cent discount to its last traded price.
Morgans handles $62m block in McMillan Shakespeare; Eagers sells down
The trade was done at a 2.2 per cent discount to the share price, with 4 million shares changing hands.
Infrastructure investor UTA draws in private wealth clients
A $200 million slice of Utilities Trust of Australia has given mum and dad investors exposure to some of the country’s most prized infrastructure assets.
Soul Patts, Brickworks agree to $14b merger; $500m raise launched
Stockbroker Aitken Mount Capital Partners pitched the equity raising to fund managers over the weekend.
Superhero’s valuation climbs to $150m in wealth management push
The superannuation and advice platform is also hiring senior figures from State Street Global Advisers and Rest Super as part of its expansion plans.
May
Metrics closes $315m bookbuild fully subscribed
Street Talk understands the book build was shut before the market closed on Thursday.
KKR signs off $1.2b MYOB refinancing, Big American enters debt stack
Street Talk understands the new loan, arranged by US and KKR Capital Markets, is structured as a uni-tranche term loan over five years.
Accolade Wines, Pernod Ricard push turnaround in debut $700m debt deal
Sources said the syndication could still be a tough grind – thanks to assumptions around synergies between the Accolade and Pernod Ricard businesses.
Transport software player EROAD’s Canadian suitor presses sell
Sources said Canaccord Genuity’s sales desk was ringing around on Constellation’s behalf, offering up to 21.3 million shares in the business.
UBS kicks off $880 million block trade in EBOS
The block trade of circa 26.7 million shares represented 13 per cent of the shares on issue.
Eucalyptus targets unicorn status in new $150m funding round
The weight-loss pill selling healthcare business has long been one of the most talked about start-up. Now it could be on the cusp of a $1 billion valuation.
PE-backed Lumus Imaging agrees terms to buy Newcastle radiology biz
It’s expected to serve as the first plank of Affinity’s strategy of ramping up growth, both organically and via acquisition.
Meet the UK hedge fund emerging as Healthscope’s kingmaker
Sources told this column the Polus contingent due to land in Sydney includes Jamie McFarlane, a portfolio manager in special situations, and Ash Thomas-Watson.